Is the use of resveratrol in the treatment and prevention of obesity premature? (Q37601527)

21 August 2017

1 reference

title

Is the use of resveratrol in the treatment and prevention of obesity premature? (English)

1 reference

21 August 2017

0 references

1 reference

Etheresia Pretorius

2

0 references

Wendy J van der Spuy

object named as

Wendy J van der Spuy

series ordinal

1

0 references

publication date

1 December 2009

1 reference

Nutrition Research Reviews

21 August 2017

1 reference

21 August 2017

22

1 reference

21 August 2017

111-117

1 reference

21 August 2017

2

1 reference

Resveratrol improves health and survival of mice on a high-calorie diet

21 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Mechanisms of endothelial dysfunction in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

High absorption but very low bioavailability of oral resveratrol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Elevation of oxidative-damage biomarkers during aging in F2 hybrid mice: protection by chronic oral intake of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Resveratrol-associated renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Effects of resveratrol on glycerol-induced renal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Resveratrol is a selective human cytochrome P450 1A1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Resveratrol in cardioprotection: a therapeutic promise of alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Estrogenic activity in white and red wine extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Pharmacological preconditioning with resveratrol: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Obesity and cardiovascular dysfunction: A role for resveratrol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Resveratrol stimulates AMP kinase activity in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Gene expression profile of aging and its retardation by caloric restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

The pharmacology and toxicology of polyphenolic-glutathione conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

Inflammatory pathways and insulin action

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

Biological effects of resveratrol

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

Adipose tissue, insulin action and vascular disease: inflammatory signals

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

Diabetes and cardiovascular disease. The "common soil" hypothesis

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

Resveratrol, a remarkable inhibitor of ribonucleotide reductase

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

https://api.crossref.org/works/10.1017%2FS0954422409990084

1 reference

7 January 2021

Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

Inhibition of human LDL oxidation by resveratrol

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed.

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin

1 reference

https://api.crossref.org/works/10.1017%2FS0954422409990084

7 January 2021

10.1017/S0954422409990084

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19772694